Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV

Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation

(2017) Normand Blais et al.   JOURNAL OF VIROLOGY

Animal models of respiratory syncytial virus infection

(2017) Geraldine Taylor   VACCINE

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

(2017) Jarrod J. Mousa et al.   Nature Microbiology

Protection of calves by a prefusion-stabilized bovine RSV F vaccine

(2017) Baoshan Zhang et al.   npj Vaccines

A Recombinant G Protein Plus Cyclosporine A–Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

(2016) Chaofan Li et al.   JOURNAL OF IMMUNOLOGY

Maternal immunization: Optimizing protection for the mother and infant

(2016) Alisa Kachikis et al.   JOURNAL OF INFECTION

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

(2016) Joanne M. Langley et al.   JOURNAL OF INFECTIOUS DISEASES

Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV

(2016) M Gordon Joyce et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV

(2016) M Gordon Joyce et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus

(2016) April M. Killikelly et al.   Scientific Reports

Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system

(2015) Irmgard Hofmann et al.   BIOTECHNOLOGY AND BIOENGINEERING

A bovine respiratory syncytial virus model with high clinical expression in calves with specific passive immunity

(2015) Krister Blodörn et al.   BMC Veterinary Research

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

(2015) Gregory M. Glenn et al.   JOURNAL OF INFECTIOUS DISEASES

Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate

(2015) Bo Liang et al.   JOURNAL OF VIROLOGY

Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera

(2015) Joan O. Ngwuta et al.   Science Translational Medicine

Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya

(2015) Joyce U. Nyiro et al.   VACCINE

Maternal immunization at the crossroads

(2015) Cynthia Pellegrini et al.   VACCINE

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

(2015) Anders Krarup et al.   Nature Communications

Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein

(2015) Jason S McLellan   Current Opinion in Virology

Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh

(2014) Helen Y. Chu et al.   JOURNAL OF INFECTIOUS DISEASES

Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation

(2014) Concepción Palomo et al.   VIROLOGY

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

(2013) Davide Corti et al.   NATURE

Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age

(2013) C. B. Hall et al.   PEDIATRICS

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

(2013) J. S. McLellan et al.   SCIENCE

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

(2013) J. S. McLellan et al.   SCIENCE

Respiratory syncytial virus vaccine development

(2013) Larry J. Anderson   SEMINARS IN IMMUNOLOGY

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

(2012) Gregory M. Glenn et al.   VACCINE

Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes

(2011) J. S. McLellan et al.   JOURNAL OF VIROLOGY

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

(2011) K. A. Swanson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

(2010) Yong Zhang et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

A review of immune transfer by the placenta

(2010) T.M. Chucri et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

Seasonal Variation of Maternally Derived Respiratory Syncytial Virus Antibodies and Association with Infant Hospitalizations for Respiratory Syncytial Virus

(2009) Lone Graff Stensballe et al.   JOURNAL OF PEDIATRICS

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Role of Neutralizing Antibodies in Protection of American Indian Infants Against Respiratory Syncytial Virus Disease

(2009) Angelia Eick et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya

(2009) Rachel Ochola et al.   PLoS One